Gene-expression profiles predict sorafenib efficacy in wild-type EGFR non-small cell lung cancer (NSCLC)

被引：0

作者：

Saintigny, Pierre ^{[1
]}

Blumenschein, George R. ^{[1
]}

Diao, Lixia ^{[1
]}

Wang, Jing ^{[1
]}

Coombes, Kevin ^{[1
]}

Liu, Suyu ^{[1
]}

Kim, Edward ^{[1
]}

Tsao, Anne ^{[1
]}

Herbst, Roy ^{[2
]}

Alden, Christine ^{[1
]}

Lee, Jack J. ^{[1
]}

Tang, Ximing ^{[1
]}

Stewart, David ^{[3
]}

Kies, Merrill ^{[1
]}

Fossella, Frank ^{[1
]}

Tran, Hai ^{[1
]}

Mao, Li ^{[4
]}

Hicks, Marshall ^{[1
]}

Erasmus, Jeremy ^{[1
]}

Gupta, Sanjay ^{[1
]}

Girard, Luc ^{[5
]}

Peyton, Michael ^{[5
]}

Davis, Suzanne ^{[1
]}

Lippman, Scott ^{[1
]}

Hong, Waun Ki ^{[1
]}

Minna, John ^{[5
]}

Wistuba, Ignacio ^{[1
]}

Heymach, John ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Yale Canc Ctr, New Haven, CT USA

[3] Univ Ottawa, Fac Med, Ottawa, ON K1N 6N5, Canada

[4] Univ Maryland, Baltimore, MD 21201 USA

[5] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA

来源：

CANCER RESEARCH | 2012年 / 72卷

关键词：

D O I：

10.1158/1538-7445.AM2012-4819

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4819

引用

页数：2

共 50 条

[1] Absence of TTF-1 Immunoreactivity Can Predict EGFR Wild-Type in Non-Small Cell Lung Cancer (NSCLC)
Bosdet, I.
Young, S. S.
Ali, R. H.
McNeil, B. K.
Wong, C.
Garbutt, K.
Karsan, A.
Ionescu, D. N.
[J]. MODERN PATHOLOGY, 2012, 25 : 474A - 474A
[2] Absence of TTF-1 Immunoreactivity Can Predict EGFR Wild-Type in Non-Small Cell Lung Cancer (NSCLC)
Bosdet, I.
Young, S. S.
Ali, R. H.
McNeil, B. K.
Wong, C.
Garbutt, K.
Karsan, A.
Ionescu, D. N.
[J]. LABORATORY INVESTIGATION, 2012, 92 : 474A - 474A
[3] ERLOTINIB IN METASTATIC, EGFR WILD-TYPE, NON-SMALL CELL LUNG CANCER (NSCLC) AS SECOND OR FURTHER LINE OF THERAPY
Hernandez, Alba
Calera, Lourdes
Alvarez, Maria
Hernando, Jorge
Torres, Irene
Pajares, Isabel
Madani, Julia
Cebollero, Ana
Anton-Torres, Antonio
Artal, Angel
[J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1017 - S1017
[4] EGFR tyrosine kinase inhibitor in advanced non-small cell lung cancer with wild-type EGFR
Wang, Z.
Wu, Y. L.
Yang, J.
Wang, B.
Huang, Y.
Zhou, Q.
Xu, C.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[5] Fingolimod sensitizes EGFR wild-type non-small cell lung cancer cells to lapatinib or sorafenib and induces cell cycle arrest
Ota, Kohki
Okuma, Takashi
De Lorenzo, Alberto
Yokota, Ayuka
Hino, Hirotsugu
Kazama, Hiromi
Moriya, Shota
Takano, Naoharu
Hiramoto, Masaki
Miyazawa, Keisuke
[J]. ONCOLOGY REPORTS, 2019, 42 (01) : 231 - 242
[6] A study of EGFR wild-type non-small cell lung cancer ALK genetic mutation
Wang, Shoufeng
Mao, Naiquan
Zuo, Chuantian
Pan, Hong
Xie, Tong
Huang, Yaoyuan
Pan, Qi
Wu, Junwei
[J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 (05) : 976 - 980
[7] Examination of the importance of RUNX category in EGFR wild-type non-small cell lung cancer
Kobayakawa, Atsushi
Takeda, Kanako
Masuda, Tatuya
Yanagida, Yohei
Obi, Natsuno
Sakuramoto, Naoya
Hada, Asuka
Horiuchi, Ayaka
Takeda, Mizuho
Sasaki, Asami
Matsuo, Hidemasa
Sugiyama, Hiroshi
Adachi, Souichi
Kamikubo, Yasuhiko
[J]. CANCER SCIENCE, 2021, 112 : 445 - 445
[8] Efficacy and Safety of Capmatinib Plus Nivolumab in Pretreated Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
Felip, E.
Minotti, V.
Tan, D.
Wolf, J.
Mark, M.
Boyer, M.
Hughes, B.
Bearz, A.
Moro-Sibilot, D.
Le, X.
Vazquez, J.
Massuti, B.
Liu, N.
Hao, L.
Cheng, Y.
Tiedt, R.
Cobo, M.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S585 - S586
[9] The efficacy of erlotinib for patients with non-small cell lung cancer with wild type of EGFR mutations
Kobayashi, Takashi
Koizumi, Tomonobu
Tanabe, Tsuyoshi
Tsushima, Kenji
Urushihata, Kazuhisa
Yamamoto, Hiroshi
Hanaoka, Masayuki
Kubo, Keishi
Koyama, Shigeru
Ooura, Nariaki
[J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S690 - S690
[10] Cost of care in EGFR mutant versus wild-type non-small cell lung cancer.
Vusqa, Urwat Til
Asawa, Palash
Miller, Katherine
Sethi, Ashish
Rodriguez, Robin Raquel
Friday, Andrew
Finley, Gene Grant
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

← 1 2 3 4 5 →